Reaction
Nephrostomy reporting signals
As of the last recalculation, Nephrostomy appears in 323 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is RELUGOLIX (PRR 39.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Relugolix | 14 | 39.9 | 40.0 |
| Regorafenib | 6 | 33.9 | 33.9 |
| Panitumumab | 7 | 29.4 | 29.4 |
| Axicabtagene Ciloleucel | 4 | 26.4 | 26.4 |
| Apalutamide | 4 | 22.2 | 22.2 |
| Enzalutamide | 16 | 18.4 | 18.4 |
| Trifluridine And Tipiracil | 3 | 18.2 | 18.2 |
| Abiraterone Acetate | 10 | 16.1 | 16.1 |